| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BRISTOL MYERS SQUIBB CO | 1.6% | $312,381 | 200,244 | BRISTOL MYERS SQUIBB CO | 31 Dec 2024 |
| Filer | Ownership | Nb Shares | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 18% | 2,252,987 | 0% | 0.11% | $4,460,914 |
| Atlas Venture Life Science Advisors, LLC | 17% | 2,092,106 | 0% | 0.55% | $4,142,370 |
| Carlyle Group Inc. | 9% | 1,102,741 | 0% | 0.05% | $2,128,290 |
| ACORN CAPITAL ADVISORS, LLC | 6.6% | 803,425 | 0% | 0.81% | $1,590,782 |
| ARCH Venture Management, LLC | 2.6% | 320,482 | 0% | 0.13% | $634,554 |
| Monaco Asset Management SAM | 2.5% | 311,137 | -47% | 0.23% | $616,051 |
| VANGUARD GROUP INC | 2.4% | 295,409 | +9.6% | 0% | $584,910 |
| Pfizer Inc | 2.3% | 277,777 | 0% | 0.13% | $549,998 |
| Sanofi | 2% | 244,083 | 0% | 0.19% | $483,284 |
| Trustees of Columbia University in the City of New York | 1.1% | 133,903 | 0% | 0.04% | $265,128 |
| MILLENNIUM MANAGEMENT LLC | 0.86% | 104,772 | -20% | 0% | $207,449 |
| BlackRock, Inc. | 0.76% | 93,005 | -48% | 0% | $184,151 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.72% | 88,496 | +44% | 0% | $175,285 |
| RENAISSANCE TECHNOLOGIES LLC | 0.39% | 47,300 | -39% | 0% | $93,654 |
| NORTHERN TRUST CORP | 0.26% | 31,953 | +23% | 0% | $63,267 |
| TWO SIGMA INVESTMENTS, LP | 0.26% | 31,506 | 0% | $62,382 | |
| ACADIAN ASSET MANAGEMENT LLC | 0.24% | 29,739 | 0% | 0% | $58,000 |
| Affinity Asset Advisors, LLC | 0.23% | 27,777 | 0% | 0.01% | $54,998 |
| STATE STREET CORP | 0.17% | 21,237 | -21% | 0% | $42,049 |
| FMR LLC | 0.13% | 15,867 | -63% | 0% | $31,417 |
| HRT FINANCIAL LP | 0.12% | 14,836 | 0% | $29,000 | |
| TWO SIGMA SECURITIES, LLC | 0.11% | 13,749 | 0% | $27,223 | |
| MORGAN STANLEY | 0.09% | 11,343 | -39% | 0% | $22,458 |
| DLK Investment Management, LLC | 0.08% | 10,333 | 0% | 0.01% | $20,459 |
| CITADEL ADVISORS LLC | 0.08% | 10,117 | 0% | $20,032 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 8,428,600 | $16,632,224 | -$986,455 | $1.98 | 52 |
| 2025 Q2 | 8,978,370 | $13,355,302 | -$657,201 | $1.49 | 59 |
| 2025 Q1 | 9,406,123 | $15,511,257 | -$5,227,234 | $1.65 | 71 |
| 2024 Q4 | 10,994,953 | $37,808,803 | -$51,251,129 | $3.44 | 88 |
| 2024 Q3 | 9,108,413 | $405,845,227 | +$55,628,540 | $44.62 | 71 |
| 2024 Q2 | 8,065,328 | $144,178,979 | +$11,388,677 | $17.95 | 54 |
| 2024 Q1 | 7,430,290 | $125,894,701 | +$125,894,701 | $17.04 | 38 |